WilmerHale Advises GE HealthCare as Lead Investor in Laza Medical's $160 Million Series B Financing

WilmerHale Advises GE HealthCare as Lead Investor in Laza Medical's $160 Million Series B Financing

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

On November 3, 2026, Laza Medical, Inc., a Shifamed portfolio company pioneering AI-powered robotic imaging solutions for cardiac interventions, announced that it has raised up to $160 million in Series B structured financing. GE HealthCare (Nasdaq: GEHC) led the round, with participation from Unorthodox Ventures, PA MedTech, and AMED.  The financing will support Laza's mission to transform the cardiac catheterization laboratory through intelligent imaging technology designed to simplify procedures, increase autonomy, alleviate resource constraints, and unlock the possibilities for future robotic-enabled interventions. 

WilmerHale is representing GE HealthCare in the transaction, with a team led by Partners Chris Barnstable-Brown, Mark Nylen, and Stephen Gillespie that also included Senior Associates Frank Wang and Kyle Kessler and Associate Kelly Pagniello on corporate matters, and Partners Ciara Baker, Kim Wethly, Amanda Albert, Ariella Feingold, Jeff Tolin, Barish Ozdamar, Omar Khan, Ariel Soiffer, Leon Greenfield, Oliver Fleischmann, Bruce Manheim, and Kirk Nahra, Counsel Ben Kelsey and Stephanie Hartmann, Associates Cole Swaffield, Sarah Litwin, and Ashley Leon, and Attorney Carla Gilbertson on equity compensation, employee benefits, employment, tax, intellectual property, technology transactions, antitrust, regulatory, and privacy matters.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel